槐耳颗粒联合经肝动脉化疗栓塞术治疗肝细胞癌的研究进展

董德硕; 刘兆玉

doi:10.3969/j.issn.1001-5256.2017.09.10.037

槐耳颗粒联合经肝动脉化疗栓塞术治疗肝细胞癌的研究进展

DOI: 10.3969/j.issn.1001-5256.2017.09.10.037

中国医科大学附属盛京医院放射科

详细信息

中图分类号: R735.7
计量
- 文章访问数: 2107
- HTML全文浏览量: 25
- PDF下载量: 382
- 被引次数: 0
出版历程
- 收稿日期: 2017-04-11
- 出版日期: 2017-10-20

Research advances in Huai'er granules combined with transarterial chemoembolization in treatment of hepatocellular carcinoma

Department of Radiology, Shengjing Hospital of China Medical University

摘要

摘要: 肝细胞癌起病隐匿,发现时多数已失去手术机会,主要采用经肝动脉化疗栓塞术（TACE）姑息治疗。然而反复TACE会导致缺氧诱导因子1（HIF-1）及血管内皮生长因子（VEGF）高表达、肝损伤、免疫功能降低,远期疗效并不理想,槐耳颗粒的引入有望改变这一现状。槐耳颗粒通过阻滞细胞周期、诱导细胞凋亡、抑制细胞增殖与侵袭、阻断乙型肝炎-肝细胞癌途径发挥抗肿瘤作用,同时,槐耳颗粒作为肝细胞癌辅助用药在多方面弥补TACE的不足之处,有效抑制HIF-1α及VEGF高表达、改善肝损伤、提高免疫力、增强化疗药效果并逆转耐药。槐耳颗粒与TACE联合治疗肝细胞癌优势显著,两者协同作用提高了抗肿瘤疗效及近、远期生存率。
- 癌,肝细胞 /
- 槐耳颗粒 /
- 化学栓塞,治疗性 /
- 综述
Abstract: Hepatocellular carcinoma ( HCC) has an insidious onset and when a confirmed diagnosis is made, most patients lose the chance for surgery and are given transarterial chemoembolization ( TACE) as palliative treatment. However, repeated TACE may lead to overexpression of hypoxia-inducible factor 1α ( HIF-1α) and vascular endothelial growth factor ( VEGF) , liver injury, and reduced immune function and has poor long-term efficacy. The introduction of Huai'er granules may help to change the current status. Studies in China and foreign countries have shown that Huai'er granules exert a remarkable anti-tumor effect by blocking cell cycle, inducing cell apoptosis, inhibiting cell proliferation and invasion, and blocking the hepatitis B-hepatocellular carcinoma pathway. Meanwhile, as an adjuvant drug for HCC, Huai'er granules cover the shortcomings of TACE from multiple aspects and can effectively inhibit the overexpression of HIF-1α and VEGF, improve liver injury and immunity, enhance the effect of chemotherapy drugs, and reverse drug resistance. Many clinical studies have confirmed the remarkable advantages of Huai' er granules combined with TACE, and their synergistic effect helps to enhance anti-tumor effect and improve short-and long-term survival rates.
- carcinoma /
- hepatocellular /
- Huaier granule /
- chemoembolization

HTML全文

参考文献(38)

[1]WALLACE MC, PREEN D, JEFFREY GP, et al.The evolving epidemiology of hepatocellular carcinoma:a global perspective[J].Expert Rev Gastroenterol Hepatol, 2015, 9 (6) :765-779.

[2]LIANG HY, LU ZM.Current status and confusion in comprehensive interventional therapy for hepatocellular carcinoma[J].J Clin Hepatol, 2016, 32 (1) :44-48. (in Chinese) 梁宏元, 卢再鸣.原发性肝癌综合介入治疗现状与困惑[J].临床肝胆病杂志, 2016, 32 (1) :44-48.

[3]WATANABE Y, NAKABA H, TANIGUCHI E, et al.Successful treatment of metastatic hepatocellular carcinoma with sorafenib combined with transcatheter arterial chemoembolization/hepatic arterial infusion chemotherapy[J].Gan To Kagaku Ryoho, 2014, 41 (12) :2110-2112.

[4]LLOVET JM, REAL MI, MONTAA X, et al.Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:a randomised controlled trial[J].Lancet, 2002, 359 (9319) :1734-1739.

[5]HU ZD, YANG AL, SU GZ, et al.Huaier restrains proliferative and invasive potential of human hepatoma SKHEP-1 cells partially through decreased Lamin B1 and elevated NOV[J].Sci Rep, 2016, 6:31298.

[6]ZHANG CS, ZHANG JL, LI X, et al.Huaier Aqueous Extract induces hepatocellular carcinoma cells arrest in S phase via JNK signaling pathway[J].Evid Based Complement Alternat Med, 2015, 2015:171356.

[7]BAO HD, LIU P, JIANG K, et al.Huaier polysaccharide induces apoptosis in hepatocellular carcinoma cells through p38 MAPK[J].Oncol Lett, 2016, 12 (2) :1058-1066.

[8]ZHENG JS, LI C, WU X, et al.Huaier polysaccharides suppresses hepatocarcinoma MHCC97-H cell metastasis via inactivation of EMT and AEG-1 pathway[J].Int J Biol Macromol, 2014, 64 (2) :106-110.

[9]ZHENG JS, LI C, WU X, et al.Astrocyte elevated gene-1 (AEG-1) shRNA sensitizes Huaier polysaccharide (HP) -induced anti-metastatic potency via inactivating downstream P13K/Akt pathway as well as augmenting cell-mediated immune response[J].Tumour Biol, 2014, 35 (3) :4219-4224.

[10]MOSER MA, KNETEMAN NM, MINUK GY.Review:research toward safer resection of the cirrhotic liver[J].HPB Surg, 2000, 11 (5) :285-297.

[11]LI C, ZHENG XL, PENG L, et al.Anticancer effect of PS-T on the experimental hepatocellular carcinoma[J].Chinese-German JClin Oncol, 2004, 3 (1) :55-59.

[12]JIA ZZ, FENG YL, SHI HB.Correlation between serum HIF-lαand VEGF level pre-and post-TACE in patients with primary liver cancer[J].Chin J Interv Imaging Ther, 2010, 7 (2) :117-120. (in Chinese) 贾中芝, 冯耀良, 施海彬.原发性肝癌TACE前后血清HIF-1α与VEGF的相关性[J].中国介入影像与治疗学, 2010, 7 (2) :117-120.

[13]COVELLO KI, SIMON MC, KEITH B.Targeted replacement of hypoxia-inducible factor-1alpha by a hypoxia inducible factor-2alpha knock-in allele promotes tumor growth[J].Cancer Res, 2005, 65 (6) :2277-2286.

[14]LI C, WU X, ZHANG HH, et al.A Huaier polysaccharide restrains hepatocellular carcinoma growth and metastasis by suppression angiogenesis[J].Int J Biol Macromol, 2015, 75:115-120.

[15]MATHONNET M, DESCOTTES B, VALLEIX D, et al.Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer、liver metastasis of colorectal cancer and hepatoeellular carcinoma[J].World J Gastroenterol, 2006, 12 (23) :3782-3783.

[16]ZHENG PX, SHU RY, ZHAO YL, et al.Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma[J].Hepatobiliary Pancreat Dis Int, 2004, 3 (3) :386-390.

[17]WANG XL, ZHANG N, HUO Q, et al.Anti-angiogenic and antitumor activities of Huaier aqueous extract[J].Oncol Rep, 2012, 28 (4) :1167-1175.

[18]CHEN DX, CHEN XP, ZHANG WG.Experimental research of the Fungi of Huaier in treating liver cancer[J].Chin J Gen Surg, 2004, 13 (8) :578-582. (in Chinese) 陈大兴, 陈孝平, 张万广.槐耳清膏治疗肝癌的实验研究[J].中国普通外科杂志, 2004, 13 (8) :578-582.

[19]ZHANG YH, MA DQ.Liver-protecting effect of S-adenosylmethionine after transarterial chemoembolization for hepatocellular carcinoma[J].Chin Hepatol, 2014, 19 (11) :862-864. (in Chinese) 张银华, 马德强.腺苷蛋氨酸对肝细胞肝癌TACE术后的护肝作用[J].肝脏, 2014, 19 (11) :862-864.

[20]XU X, WEI Q, WANG K, et al.Anticancer effects of Huaier are associated with down regulation of P53[J].Asian Pac J Cancer Prev, 2011, 12 (9) :2251-2254.

[21]REN JZ, ZHENG CS.Effect of Huaier extract combined with chemoembolization on the expression of VEGF, MVD and hepatic function of rabbit VX2 hepatocarcinoma[J].World Chin J Dig, 2009, 17 (5) :449-453. (in Chinese) 任建庄, 郑传胜.槐耳清膏联合化疗栓塞对兔VX2肝癌肝功能、VEGF及MVD的影响[J].世界华人消化杂志, 2009, 17 (5) :449-453.

[22]WANG GC, SHI GX.The study on cell immunologic function of hepatocellular carcinoma[J].Chin J Gastroenterol Hepatol, 2011, 20 (5) :468-471. (in Chinese) 王拱辰, 施广霞.肝细胞癌患者免疫功能的研究[J].胃肠病学和肝病学杂志, 2011, 20 (5) :468-471.

[23]LI C, WU X, ZHANG HH, et al.A Huaier polysaccharide inhibits hepatocellular carcinoma growth and metastasis[J].Tumour Biol, 2015, 36 (3) :1739-1745.

[24]WANG P, ZHONG W.Protective effect of Huaier granules on immune function after TACE in patients with liver cancer[J].China Mod Doct, 2013, 51 (36) :58-60. (in Chinese) 汪平, 仲炜.槐耳颗粒对肝癌栓塞化疗后免疫功能的影响[J].中国现代医生, 2013, 51 (36) :58-60.

[25]HU ZD, YANG AL, FAN HT, et al.Huaier aqueous extract sensitizes cells to rapamycin and cisplatin through activating m TOR signaling[J].J Ethnopharmacol, 2016, 186:143-150.

[26]ZHANG JB, SUN HC.Inhibitory effect of Huai’er cream combined with fluorouracil on growth and metastasis of liver cancer:an experimental study[J].Chin J Surg, 2007, 45 (9) :632-634. (in Chinese) 张巨波, 孙惠川.槐耳清膏联合氟尿嘧啶抑制肝癌生长转移的实验研究[J].中华外科杂志, 2007, 45 (9) :632-634.

[27]LIU N, GENG XP.MDR-reversing effect of Extractum trametes robiniophila murr on human hepatocellular carcinoma Hep G2/ADM in vitro[J].Chin J Hepatobiliary Surg, 2007, 13 (6) :385-388. (in Chinese) 刘念, 耿小平.槐耳清膏体外逆转人肝癌细胞Hep G2/ADM多药耐药性[J].中华肝胆外科杂志, 2007, 13 (6) :385-388.

[28]YU Z, WU T, ZHANG Y.The reversal effects of trametes robiniophila murr.on multidrug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-Fu[J].J Oncol, 2013, 19 (6) :443-447. (in Chinese) 喻喆, 吴涛, 张阳.槐耳清膏体外逆转人肝癌耐药细胞BEL-7402/5-Fu多药耐药性[J].肿瘤学杂志, 2013, 19 (6) :443-447.

[29]WU H.Huaier granules combined with chemoembolization in treating primary liver cancer in 96 cases[J].China Pharm, 2014, 23 (3) :16-18. (in Chinese) 吴晖.槐耳颗粒联合化疗栓塞术治疗原发性肝癌96例[J].中国药业, 2014, 23 (3) :16-18.

[30]LI JD, PENG Y, DAI Y.Clinical effects of Huaier and transarterial chemoembolization (TACE) in treatment of advanced hepatocellular carcinoma[J].Med J West China, 2010, 22 (3) :418-420. (in Chinese) 李敬东, 彭勇, 戴毅.槐耳颗粒联合肝动脉灌注化疗栓塞治疗晚期肝癌的临床研究[J].西部医学, 2010, 22 (3) :418-420.

[31]ZHAO GS, LIU Y, ZHANG YW.Huaier granules combined with intraarterial chemoembolization for the treatment of hepatocellular carcinoma[J].Chin J Gen Surg, 2013, 28 (6) :440-443. (in Chinese) 赵广生, 刘影, 张跃伟.明胶海绵微粒与洛铂经肝动脉化疗栓塞联合槐耳颗粒治疗原发性肝癌[J].中华普通外科杂志, 2013, 28 (6) :440-443.

[32]DU GQ, DONG ZQ.Clinical observation of huaier granule combined with TACE for advanced hepatocellular carcinoma[J].Guide China Med, 2012, 10 (21) :446-447. (in Chinese) 杜更全, 董志强.槐耳颗粒联合TACE治疗中晚期肝癌的疗效观察[J].中国医药指南, 2012, 10 (21) :446-447.

[33]CHEN WL, WU HJ, WEI W.Clinical effect of interventional treatment combined with Huai'er granules in treatment of primary liver cancer[J].Chin J Misdiagn, 2010, 10 (21) :5125. (in Chinese) 陈文林, 吴海江, 魏卫.介入治疗加槐耳颗粒治疗原发性肝癌临床观察[J].中国误诊学杂志, 2010, 10 (21) :5125.

[34]XIE XW, YANG JK.Advances in phlegm treatment of liver cancer[J].J Changcun Univ Chin Med, 2015, 31 (6) :1153-1156. (in Chinese) 谢晓蔚, 杨金坤.化痰法治疗肝癌的研究[J].长春中医药大学学报, 2015, 31 (6) :1153-1156.

[35]SONG HX, QIAO F, SHAO M.Research advances in traditional Chinese medicine treatment for primary liver cancer[J].J Clin Hepatol, 2016, 32 (1) :174-177. (in Chinese) 宋慧娴, 乔飞, 邵铭.中医药治疗原发性肝癌的研究进展[J].临床肝胆病杂志, 2016, 32 (1) :174-177.

[36]HAN ZY, HAN Z, ZHU JF.Traditional Chinese medicine treatment of primary liver cancer[J].J Changchun Univ Chin Med, 2016, 32 (2) :426-429.韩中颖, 韩政, 祝峻峰.中医药治疗原发性肝癌临床研究进展[J].长春中医药大学学报, 2016, 32 (2) :426-429. (in Chinese)

[37]YE SL, CHEN XP, YANG JM.Safety and effcacy of sorafenib therapy in patients with hepatocellular carcinoma:fnal outcome from the Chinese patient subset of the GIDEON study[J].Oncotarget, 2016, 7 (6) :6639-6648.

[38]SONG XJ, LI YM, ZHANG HW, et al.The anticancer effect of Huaier (Review) [J].Oncol Rep, 2015, 34 (1) :12-21.

施引文献

资源附件(0)

访问统计